Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma of Gastric”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT04282044
What this trial is testing

Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies

Who this might be right for
Solid Tumor, AdultTriple Negative Breast CancerColorectal Cancer+6 more
BioEclipse Therapeutics 60
Early research (Phase 1)Study completedNCT00544193
What this trial is testing

Gemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerGastric Cancer+2 more
City of Hope Medical Center 16
Testing effectiveness (Phase 2)Looking for participantsNCT07327229
What this trial is testing

A Phase Ib/II Study of ATG-022 Plus Pembrolizumab With/Without Chemotherapy in Participants With Claudin (CLDN) 18.2-positive, HER2-negative, Unresectable or Metastatic Gastric or Gastroesophageal Junction AdenocarcinomaUnresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
Antengene Biologics Limited 132
Testing effectiveness (Phase 2)Looking for participantsNCT06710756
What this trial is testing

Lead-212 PSV359 Therapy for Patients With Solid Tumors

Who this might be right for
Pancreatic Ductal AdenocarcinomaGastric CancerEsophageal Cancer+5 more
Perspective Therapeutics 112
Testing effectiveness (Phase 2)UnknownNCT01641783
What this trial is testing

Efficacy and Safety Study of ABI-007 Plus Capecitabine as First-line Chemotherapy for Advanced Gastric Cancer Patients

Who this might be right for
Gastric Adenocarcinoma
Yanqiao Zhang 40
Not applicableStudy completedNCT06347757
What this trial is testing

A 3-Arm Study Comparing the Efficacy of Anti-Reflux Reconstruction Protocols After Laparoscopic Proximal Gastrectomy

Who this might be right for
Anti-Reflux Alimentary ReconstructionLaparoscopic Proximal GastrectomySiewert Type II/III Adenocarcinoma of the Esophagogastric Junction
Northern Jiangsu People's Hospital 180
Early research (Phase 1)Ended earlyNCT02862535
What this trial is testing

Study to Evaluate the Safety and Tolerability of Andecaliximab as Monotherapy and in Combination With Anti-Cancer Agents in Japanese Participants With Gastric or Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Gastric Adenocarcinoma
Gilead Sciences 36
Testing effectiveness (Phase 2)UnknownNCT05346874
What this trial is testing

Neoadjuvant TACiE in Locally Advanced Gastric Cancer

Who this might be right for
Gastric Cancer
Shanghai Zhongshan Hospital 37
Not applicableUnknownNCT03626610
What this trial is testing

Prehabilitation of Patients With oEsophageal Malignancy Undergoing Peri-operative Treatment

Who this might be right for
Oesophageal AdenocarcinomaChemotherapy EffectSurgery
Guy's and St Thomas' NHS Foundation Trust 66
Testing effectiveness (Phase 2)UnknownNCT05019794
What this trial is testing

Infigratinib in Subjects With GC or GEJ With FGFR2 Amplification or Other Solid Tumors With Other FGFR Alterations

Who this might be right for
Gastric CancerGastroesophageal Junction AdenocarcinomaSolid Tumor
LianBio LLC 80
Testing effectiveness (Phase 2)Study completedNCT00003237
What this trial is testing

Combination Chemotherapy After Surgery in Treating Patients With Cancer of the Esophagus or Stomach

Who this might be right for
Esophageal CancerGastric Cancer
Eastern Cooperative Oncology Group 55
Testing effectiveness (Phase 2)Looking for participantsNCT06761846
What this trial is testing

Sintilimab Combined With Chemotherapy as Adjuvant Treatment for Phase III GC and GEJ

Who this might be right for
Gastric AdenocarcinomaEsophagogastric Junction Adenocarcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 70
Testing effectiveness (Phase 2)UnknownNCT04631731
What this trial is testing

Risk Factors of Immune-ChEckpoint Inhibitors MEdiated Liver, Gastrointestinal, Endocrine and Skin Toxicity

Who this might be right for
Lung Cancer, Nonsmall CellRenal Cell CarcinomaMelanoma+4 more
Western Sydney Local Health District 200
Testing effectiveness (Phase 2)Study completedNCT02449551
What this trial is testing

Study of AZD6094 (Volitinib) in Advanced Gastric Adenocarcinoma Patients With MET Amplification as a Third-line Treatment

Who this might be right for
Advanced Gastric Adenocarcinoma
Samsung Medical Center 16
Large-scale testing (Phase 3)UnknownNCT02144727
What this trial is testing

A Clinical Trial of D1+ Versus D2 Distal Gastrectomy for Stage IB & II Advanced Gastric Cancer

Who this might be right for
Gastric Adenocarcinoma
National Cancer Center, Korea 1,880
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07139951
What this trial is testing

Hyperthermic Intraperitoneal Chemotherapy With Cisplatin and Paclitaxel for Gastric Cancer at High Risk of Peritoneal Recurrence

Who this might be right for
Clinical Stage I Gastric Cancer AJCC v8Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8Clinical Stage II Gastric Cancer AJCC v8+5 more
Mayo Clinic 16
Testing effectiveness (Phase 2)UnknownNCT04572542
What this trial is testing

Camrelizumab Combined With Apatinib Mesylate Tablets and Nab-paclitaxel in the Second-line Treatment of Advanced Gastric Cancer

Who this might be right for
Locally Advanced or Metastatic Gastric Adenocarcinoma
The First Affiliated Hospital of Xiamen University 46
Large-scale testing (Phase 3)Active Not RecruitingNCT06351020
What this trial is testing

LM-302 for the Treatment of Subjects With Claudin18.2-Positive Gastric and Gastroesophageal Junction Adenocarcinoma.

Who this might be right for
Locally Advanced or Metastatic GC and GCJ Adenocarcinoma
LaNova Medicines Zhejiang Co., Ltd. 387
Not applicableActive Not RecruitingNCT03997162
What this trial is testing

Early Recovery After Surgery Protocol in Improving Quality of Life in Participants With Stage 0-IIIC Gastric Cancer Undergoing Surgery

Who this might be right for
Clinical Stage 0 Gastric Cancer AJCC v8Clinical Stage I Gastric Cancer AJCC v8Clinical Stage II Gastric Cancer AJCC v8+15 more
City of Hope Medical Center 52
Testing effectiveness (Phase 2)Looking for participantsNCT07186842
What this trial is testing

A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9

Who this might be right for
Advanced Solid Cancers
BioNTech SE 245
Next Page